| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pathology and Veterinary Clinics of the University of Trás os Montes e Alto Douro, Vila Real, Portugal (AG, AA); Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal (FG, FS); Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal (FG); and Medical Faculty, University of Porto, Porto, Portugal (FS)
Several immunohistochemical markers have been used to demonstrate the presence of myoepithelial cells in order to determine their role in the histogenesis of mammary tumors. p63, a recently characterized p53 homologue, is consistently expressed in myoepithelial cells of the human breast; however, no assessment of its immunoreactivity has been reported so far in canine mammary tissues. We investigated p63 immunohistochemical expression, as a novel myoepithelial cell nuclear marker, in 81 samples of normal (n = 2), hyperplastic (n = 11), and neoplastic (n = 68) canine mammary tissues. Myoepithelial phenotype was confirmed by using complementary monoclonal antibodies: alpha-smooth muscle actin, cytokeratin 14, cytokeratin AE1/AE3, and vimentin. p63 expression was observed in 91.4% (74/81) of the samples evaluated. Normal mammary glands, mammary hyperplasias, and benign tumors showed 100% immunoreactivity, with p63 expression restricted to myoepithelial cell nuclei. In general, benign mixed tumors showed a basal cell compartment immunoreactive to p63, with a gradual decrease of its expression during myoepithelial transformation. p63 expression was found in 72% of malignant tumors, allowing myoepithelial or basal cell identification in spindle-cell carcinomas (2/2), tubulopapillary carcinomas (8/9), solid carcinomas (7/10), and carcinosarcomas (1/3). The osteosarcoma analyzed was p63 negative. In our series, stromal components were consistently nonreactive to p63. In conclusion, the present study reveals p63 as a sensitive and highly specific marker of myoepithelial cells in canine mammary tissues, and the authors suggest p63 as an additional marker for defining myoepithelial histogenesis.
Key words: Dogs; immunohistochemistry; mammary gland; myoepithelial cell; p63.
Request reprints from Dr. F. Schmitt, IPATIMUP, R. Roberto Frias, S/N, 4200 Porto (Portugal). E-mail: fernando.schmitt{at}ipatimup.pt.
This article has been cited by other articles:
 |
|
 |
|
  F. Sassi, G. Sarli, B. Brunetti, F. Morandi, and C. Benazzi Immunohistochemical characterization of mammary squamous cell carcinoma of the dog J Vet Diagn Invest, November 1, 2008; 20(6): 766 - 773. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Wensman, V. Flama, G. Pejler, and E. Hellmen Plasticity of Cloned Canine Mammary Spindle Cell Tumor, Osteosarcoma and Carcinoma Cells Vet. Pathol., November 1, 2008; 45(6): 803 - 815. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Maratea, J. A. Ramos-Vara, L. A. Corriveau, and M. A. Miller Testicular Interstitial Cell Tumor and Gynecomastia in a Rabbit Vet. Pathol., July 1, 2007; 44(4): 513 - 517. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. N. Z. Ramalho, A. Ribeiro-Silva, G. D. Cassali, and S. Zucoloto The Expression of p63 and Cytokeratin 5 in Mixed Tumors of the Canine Mammary Gland Provides New Insights into the Histogenesis of These Neoplasms. Vet. Pathol., July 1, 2006; 43(4): 424 - 429. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
